ArticleInternational journal of molecular sciences2024
Structure and Properties of Poly(Ethylene-co-vinyl Acetate) Nanocomposites with Dual-Functionalized Dolomite Nanoparticles.
Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Poly(ethylene-co-vinyl acetate) (PEVAc) is a copolymer that consists of non-polar polyethylene (PE) and a polar polyvinyl acetate (PVAc) monomer. PEVAc has high elasticity and is resilient, making it suitable for a variety of applications. However, the tensile strength of this copolymer needs to be improved for specific applications that require enough strength to tolerate high external tension or stress. This study proposed the use of dual-functionalized dolomite nanoparticles (DF-DNPs) composed of polar and non-polar nano-dolomite (P-DNPs and NP-DNPs) as nanofillers to reinforce the PEVAc. PEVAc/DF-DNP film appears to have a more homogeneous mixture, which is better for forming an optimal nanocomposite material. It also exhibits the highest tensile strength (10.48 MPa), elongation at break (1175.73%), and tensile toughness (62.12 MPa), which are higher by increments of 46.8%, 9.4%, and 20.3%, respectively, as compared to the neat PEVAc. The result proved that using DF-DNPs as a nanofiller can improve the strength of PEVAc while maintaining its flexibility to avoid brittleness of the nanocomposite film. Furthermore, its thermal characteristics were also successfully enhanced. A biostability assessment showed that the use of DF-DNPs as nanofiller caused the PEVAc copolymer to achieve the best water resistance, as it only exhibited a 2.63% weight increase, the lowest reduction in tensile properties among the studied fillers, and the best retention in surface degradation upon 3-month exposure to the in vitro environment. These findings indicate that the DF-DNPs help in developing a homogeneous nanocomposite by interacting with PE and PVAc.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.